Debate surrounds the ML tech behind Moderna's cancer vaccine
iskander · x · 2026-08-20
Commenting on the Merck/Moderna cancer vaccine news, the author analyzes the potential machine learning techniques used in their antigen selection process. The discussion speculates on whether they utilized legacy neural networks like netMHCpan or MHCFlurry, or if more advanced post-GPT models were involved. The author emphasizes that clinical success remains significant regardless of whether pre-GPT ML methods were employed.
Related event: How AI Helps Moderna's Personalized Cancer Vaccine(4 posts)→
More from Research
- Dev critiques compiling fast programs into slow neural nets: fun, but not useful — ctjlewis · 2026-10-16
- New paper uses revealed-preference methods to unpack why AI agents cooperate — brwilder · 2026-10-16
- Logit lens on a Beat Saber finetune reveals it reuses language grammar circuits — ctjlewis · 2026-10-16
- 128×128 record stands: how intermediate-work experiments foreshadowed reasoning models — ctjlewis · 2026-10-16
- TeamFusion: preference-based AI proxies debate to preserve minority views in team decisions — burkov · 2026-10-16
- MIT's C-GMT gives humanoid robots whole-body compliance without sacrificing motion tracking — MIT_CSAIL · 2026-10-16